PUBLISHER: Grand View Research | PRODUCT CODE: 1941500
PUBLISHER: Grand View Research | PRODUCT CODE: 1941500
The global hydrogen peroxide sterilizers market size was estimated at USD 1.20 billion in 2025 and is projected to reach USD 3.15 billion by 2033, growing at a CAGR of 13.03% from 2026 to 2033. The growth is primarily driven by increasing demand for advanced sterilization solutions in the healthcare and pharmaceutical sectors, rising awareness about hospital-acquired infections, and the adoption of next-generation sterilization technologies, such as vaporized and plasma-based systems.
Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and structural heart disorders, significantly drive the hydrogen peroxide sterilizers industry due to the rising volume of diagnostic and interventional cardiac procedures worldwide. The growing use of minimally invasive techniques, such as angioplasty, stent placement, catheter-based valve repair, and electrophysiology procedures, has increased reliance on sophisticated, heat- and moisture-sensitive instruments, including catheters, endoscopes, and robotic-assisted surgical tools.
Hydrogen peroxide-based sterilization systems, particularly vaporized and plasma technologies, are preferred in cardiovascular care settings as they provide rapid cycle times, high material compatibility, and effective microbial elimination without damaging delicate device components. In addition, strict infection control standards in cardiac catheterization labs, operating rooms, and hybrid surgical suites further support the adoption of hydrogen peroxide sterilizers, as they help healthcare facilities meet regulatory compliance while reducing the risk of post-procedural infections and improving patient outcomes.
Tuberculosis (TB) significantly drives the hydrogen peroxide sterilizers industry due to the need for strict infection prevention and control in healthcare and laboratory settings. As an airborne infectious disease, TB increases the risk of cross-contamination during diagnostic and treatment procedures, including bronchoscopy, sputum sample handling, and laboratory culture testing. These procedures rely on reusable, heat- and moisture-sensitive medical instruments that require reliable low-temperature sterilization. Hydrogen peroxide-based sterilizers, particularly vaporized and plasma systems, are widely adopted as they provide rapid, high-efficacy microbial inactivation without damaging delicate devices. The high TB burden in regions such as South-East Asia and Africa, coupled with expanding government-supported TB control programs and diagnostic infrastructure, is accelerating demand for compliant, efficient sterilization technologies, thereby supporting market growth.
The increasing popularity of vaporized hydrogen peroxide sterilization is anticipated to boost market growth in the forecast years. Supportive government rules and regulations for this sterilization technique are expected to boost the demand for low-temperature sterilizers that use vaporized hydrogen peroxide sterilization methods. For instance, in January 2024, Vaporized Hydrogen Peroxide (VHP), a low-temperature sterilization technique, was approved by the FDA to sterilize medical devices. With this authorization, the agency facilitated broader adoption of VHP as a sterilization technique for the medical device industry. Such approvals from the regulatory authorities for vaporized hydrogen peroxide are anticipated to boost market growth in the forecast years.
Global Hydrogen Peroxide Sterilizers Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hydrogen peroxide sterilizers market report based on the modality, type, device compatibility, end use, region: